Pablo Iglesias
- Biomedical Engineering
- Public Health, Environmental and Occupational Health top 10%
- Molecular Biology
- Physiology
- Biomaterials top 10%
- Co-authors
- José A. CostoyaPablo TaboadaAntonio TopeteManuel Alatorre‐MedaVı́ctor MosqueraSílvia BarbosaEva Villar‐ÁlvarezValentina Ruíz-Gutiérrez
- Topics
- Cancer, Hypoxia, and Metabolism (4 papers)Nanoplatforms for cancer theranostics (4 papers)PARP inhibition in cancer therapy (3 papers)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Pablo Iglesias
15 papers receiving 481 citations
Peers
Comparison fields: 5 of 91
- Biomedical Engineering 160
- Public Health, Environmental and Occupational Health 154
- Molecular Biology 115
- Physiology 105
- Biomaterials 95
Countries citing papers authored by Pablo Iglesias
This map shows the geographic impact of Pablo Iglesias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Iglesias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Iglesias more than expected).
Fields of papers citing papers by Pablo Iglesias
This network shows the impact of papers produced by Pablo Iglesias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Iglesias. The network helps show where Pablo Iglesias may publish in the future.
Co-authorship network of co-authors of Pablo Iglesias
This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Iglesias. A scholar is included among the top collaborators of Pablo Iglesias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Iglesias. Pablo Iglesias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 2 | |
| 4 | 8 | |
| 5 | 14 | |
| 6 | 10 | |
| 7 | 5 | |
| 8 | 155 | |
| 9 | 21 | |
| 10 | 11 | |
| 11 | 4 | |
| 12 | 17 | |
| 13 | 39 | |
| 14 | 26 | |
| 15 | 145 | |
| 16 | 28 |
About Pablo Iglesias
Pablo Iglesias is a scholar working on Cancer Research, Biomaterials and Clinical Biochemistry, having authored 16 papers that have together received 490 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Nanoplatforms for cancer theranostics (4 papers) and PARP inhibition in cancer therapy (3 papers). The work is most often cited by research in Biomaterials (95 citations), Public Health, Environmental and Occupational Health (154 citations) and Physiology (105 citations). Pablo Iglesias has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include José A. Costoya, Pablo Taboada, Antonio Topete, Manuel Alatorre‐Meda, Vı́ctor Mosquera, Sílvia Barbosa, Eva Villar‐Álvarez, Valentina Ruíz-Gutiérrez, Itzíar Zazpe and Ana Sánchez‐Tainta. Their work appears in journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.